News

Tividenofusp alfa is a novel central nervous system-penetrant enzyme replacement therapy designed to address the neurological manifestations of MPS II by delivering IDS into the brain and body.
Panaji: The directorate of food and drugs administration (FDA) directed a catering business at Parra, supplying tiffins to ...
In addition to finding these dyes in brightly colored processed foods, the researchers also found them in more muted foods ...
The lawsuit argues that the HHS secretary’s withdrawal of public vaccine advice reduces access to vaccines for some people.
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
SpyGlass Pharma Inc. has raised a $75 million Series D round that brings the company closer to commercializing its ...
The medications still amount to around $500 per month for those without insurance—out of reach for many patients. And even ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., who is making strides in his war against synthetic food dyes, ...
Sunscreen is not bad for your skin, but some formulations can cause issues for people with acne or allergy-prone skin, or who ...